PET/CT scans to compare two tracers in FAP or SSTR2-positive cancer
Part of Cancer clinical trials.
This study compares two special PET/CT scan tracers—68Ga-FAPI-LM3 and 18F-FDG—to see how well they detect cancer that shows FAP or SSTR2 signals. It may help doctors choose better imaging to find or assess certain tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- Your cancer is suspected or newly found, or it has been diagnosed before.
- Your tests suggest the cancer shows FAP and/or SSTR2 signals (such as from imaging or pathology).
- You have a plan to get both scan types: 18F-FDG PET/CT and 68Ga-FAPI-LM3 PET/CT.
- You (or your legal representative) can sign consent and agree to the study; if applicable, a child would also assent.
- You do not have a non-cancer (benign) disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of PET/CT scans—one that uses FDG and one that uses FAPI—to help doctors see and evaluate cancer in different situations. It may help improve how well scans detect tumors and guide care, though it requires getting both scans scheduled.
This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.
This trial tests a special PET scan using a tracer that attaches to certain markers (PSMA and FAP) found on some cancers. It aims to help doctors see where the cancer is, possibly leading to better treatment decisions.
This study uses a special PET scan called 18F-FAPI-04 to take detailed images of different kinds of cancer. It aims to see if this scan can help doctors better find and monitor tumors.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This trial tests a new PET/CT scan that uses a special tracer (68Ga-FAPI-Biotin) to help detect and see various solid tumors. It may provide more detailed images to guide treatment decisions.
Hear when a new FAP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.